ICON Public Limited Company (ICLR)
ICLR Stock Price Chart
Explore ICON Public Limited Company interactive price chart. Choose custom timeframes to analyze ICLR price movements and trends.
ICLR Company Profile
Discover essential business fundamentals and corporate details for ICON Public Limited Company (ICLR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
15 May 1998
Employees
41.25K
Website
https://www.iconplc.comCEO
Steven A. Cutler MBA,
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
ICLR Financial Timeline
Browse a chronological timeline of ICON Public Limited Company corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 17 Feb 2026
Upcoming earnings on 22 Oct 2025
EPS estimate is $3.30.
Earnings released on 23 Jul 2025
EPS came in at $3.26 surpassing the estimated $3.18 by +2.52%, while revenue for the quarter reached $2.02B , beating expectations by +1.46%.
Earnings released on 30 Apr 2025
EPS came in at $3.19 surpassing the estimated $3.11 by +2.57%, while revenue for the quarter reached $2.00B , missing expectations by -0.32%.
Earnings released on 19 Feb 2025
EPS came in at $3.43 surpassing the estimated $3.41 by +0.59%, while revenue for the quarter reached $2.04B , beating expectations by +0.24%.
Earnings released on 23 Oct 2024
EPS came in at $3.35 falling short of the estimated $3.85 by -12.99%, while revenue for the quarter reached $2.03B , missing expectations by -0.31%.
Earnings released on 24 Jul 2024
EPS came in at $3.75 surpassing the estimated $3.68 by +1.90%, while revenue for the quarter reached $2.12B , missing expectations by -0.79%.
Earnings released on 24 Apr 2024
EPS came in at $3.47 surpassing the estimated $3.41 by +1.76%, while revenue for the quarter reached $2.09B , beating expectations by +0.15%.
Earnings released on 21 Feb 2024
EPS came in at $3.46 surpassing the estimated $3.44 by +0.58%, while revenue for the quarter reached $2.07B , missing expectations by -1.19%.
Earnings released on 25 Oct 2023
EPS came in at $3.30 surpassing the estimated $3.28 by +0.61%, while revenue for the quarter reached $2.06B , missing expectations by -1.74%.
Earnings released on 26 Jul 2023
EPS came in at $3.11 surpassing the estimated $3.08 by +0.97%, while revenue for the quarter reached $2.02B , missing expectations by -1.61%.
Earnings released on 26 Apr 2023
EPS came in at $2.90 falling short of the estimated $2.98 by -2.68%, while revenue for the quarter reached $1.98B , missing expectations by -1.94%.
Earnings released on 22 Feb 2023
EPS came in at $3.13 surpassing the estimated $3.06 by +2.29%, while revenue for the quarter reached $1.96B , missing expectations by -0.79%.
Earnings released on 2 Nov 2022
EPS came in at $3.00 surpassing the estimated $2.93 by +2.39%, while revenue for the quarter reached $1.94B , beating expectations by +0.36%.
Earnings released on 27 Jul 2022
EPS came in at $2.86 surpassing the estimated $2.79 by +2.51%, while revenue for the quarter reached $1.94B , beating expectations by +0.39%.
Earnings released on 27 Apr 2022
EPS came in at $2.76 surpassing the estimated $2.71 by +1.85%, while revenue for the quarter reached $1.90B , beating expectations by +0.73%.
Earnings released on 22 Feb 2022
EPS came in at $2.63 matching the estimated $2.63, while revenue for the quarter reached $1.89B , missing expectations by -0.56%.
Earnings released on 3 Nov 2021
EPS came in at $2.55 surpassing the estimated $2.43 by +4.94%, while revenue for the quarter reached $1.87B , beating expectations by +5.19%.
Earnings released on 21 Jul 2021
EPS came in at $2.12 surpassing the estimated $2.10 by +0.95%, while revenue for the quarter reached $871.16M , missing expectations by -52.29%.
Earnings released on 28 Apr 2021
EPS came in at $2.06 surpassing the estimated $1.97 by +4.57%, while revenue for the quarter reached $858.20M , beating expectations by +14.27%.
Earnings released on 24 Feb 2021
EPS came in at $1.90 surpassing the estimated $1.83 by +3.83%, while revenue for the quarter reached $760.23M .
Earnings released on 21 Oct 2020
EPS came in at $1.72 surpassing the estimated $1.53 by +12.42%, while revenue for the quarter reached $701.73M , beating expectations by +12.42%.
ICLR Stock Performance
Access detailed ICLR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.